RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A DealsONCY's immune molecule platform therapy pelareorep is entirely "Phase 3 ready". Definitely resulting from the Bracelet-1 Phase 2 clinical trial in metastatic breast cancer and potentially from the Goblet 1/2 clinical trial in pancreatic cancer.
Unfortunately bad actors like Quention30 post nothing other than "trumped-up" disinformation the kind of junk once spread by the likes of Sam Bankman-Fried.